Analysts Rushing To Raise Priceline Targets… Too Late? (PCLN)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Priceline.com Inc. (NASDAQ: PCLN) is hitting yet another year high after beating earnings, raising estimates, and calling for continued strength and growth in its domestic and international bookings. While shares are up over 7% at $634.00, we could not help but notice some key price changes from Wall Street analysts today. Some of these seem hard to fathom after the 40% gain we have seen in recent weeks, but here are some of the price targets raised from analysts:
- Benchmark raised its target to $692 from $638;
- Citibank raised its target to $850 from $700;
- Credit Suisse raised its target to $790 from $710;
- Stifel Nicolaus raised its target to $750 from $555.
Valuation is causing some concern at one research firm. S&P Capital IQ downgraded Priceline to Hold from Buy based on excessive share gains and on its valuation versus prospects for more growth. The prior 52-week range was $411.26 to $597.00 and this stock is almost at its all-time high from the dot-com bubble. Priceline now has a market cap of $31.6 billion.
Contact [email protected] for any questions or corrections.



